Profitability Ratios
| Ratio |
Value |
| GP Margin |
70.2% |
| EBIT Margin |
16.8% |
| EBITDA Margin |
24.9% |
| Operating Margin |
16.4% |
| Pretax Margin |
15.3% |
| Cont. Ops Margin |
12.5% |
| Net Margin |
12.6% |
| Bottom Line Margin |
12.6% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.46 |
| Quick Ratio |
1.14 |
| Solvency Ratio |
0.166 |
| Cash Ratio |
0.26 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
20.97 |
| PEG Ratio |
11.30 |
| Forward PEG |
11.30 |
| Price/Book |
1.50 |
| Price/Sales |
2.63 |
| Price/FCF |
19.80 |
| Price/Op Cash Flow |
12.84 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.1348 |
| Debt/Equity |
0.2310 |
| Debt/Capital |
0.1877 |
| Long-Term Debt/Capital |
0.1320 |
| Financial Leverage |
1.71 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
4.45 |
| Operating Cash Flow Ratio |
0.311 |
| Operating Cash Flow/Sales |
20.5% |
| Free Cash Flow/Operating Cash Flow |
64.8% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.03 |
| Interest Coverage |
11.6484 |
| Short-Term Operating Cash Flow Coverage |
2.16 |
| Operating Cash Flow Coverage |
0.51 |
| Capital Expenditure Coverage |
2.84 |
| Dividend + Capital Expenditure Coverage |
1.15 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
84.6043% |
| Dividend Yield |
4.0354% |
| Dividend Yield % |
4.0354% |
| Dividend Per Share |
1.8795 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
17.69 |
| EPS |
2.222 |
| Debt/Share |
7.4031 |
| Cash/Share |
3.17 |
| Book Value/Share |
31.11 |
| Tangible BV/Share |
4.73 |
| Equity/Share |
30.97 |
| Operating Cash Flow/Share |
3.628 |
| Capital Expenditure/Share |
1.277 |
| FCF/Share |
2.352 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.823 |
| Earnings Before Tax/EBIT |
0.932 |
| Price/Fair Value |
1.50 |
| Debt/Market Cap |
0.1373 |
| Effective Tax Rate |
17.8% |
| Enterprise Value Multiple |
11.51 |
SNY - Sanofi